This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n13http://bio2rdf.org/drugbank:
n9http://linked.opendata.cz/resource/drugbank/drug/DB01524/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n6http://linked.opendata.cz/resource/drugbank/drug/DB01524/identifier/pubchem-substance/
n12http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n7http://linked.opendata.cz/resource/drugbank/drug/DB01524/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n10http://linked.opendata.cz/resource/drugbank/drug/DB01524/identifier/chemspider/

Statements

Subject Item
n2:DB01524
rdf:type
n3:Drug
n3:description
An intermediate in testosterone biosynthesis, found in the testis or the adrenal glands. Androstenediol, derived from dehydroepiandrosterone by the reduction of the 17-keto group (17-hydroxysteroid dehydrogenases), is converted to testosterone by the oxidation of the 3-beta hydroxyl group to a 3-keto group (3-hydroxysteroid dehydrogenases). [PubChem]
n3:group
illicit experimental
owl:sameAs
n12:DB01524 n13:DB01524
dcterms:title
5-Androstenediol
adms:identifier
n6:46507476 n7:DB01524 n9:223407 n10:194034
n3:IUPAC-Name
n4:271B5206-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B520C-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B520B-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B5208-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B5209-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B520A-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B5204-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B5205-363D-11E5-9242-09173F13E4C5 n4:271B5202-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B5203-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B5212-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B5213-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B520D-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B520E-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B5210-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B520F-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B5211-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B5218-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B521A-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B521B-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B5217-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B5216-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B5219-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B5207-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B5214-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B5215-363D-11E5-9242-09173F13E4C5